Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1974 1
1975 1
1976 3
1977 1
1978 1
1979 1
1981 2
1983 3
1984 2
1985 3
1986 6
1987 1
1988 3
1989 4
1990 3
1991 2
1992 8
1993 8
1994 7
1995 6
1996 5
1997 11
1998 12
1999 11
2000 10
2001 8
2002 13
2003 13
2004 13
2005 19
2006 15
2007 26
2008 17
2009 23
2010 19
2011 17
2012 33
2013 24
2014 32
2015 29
2016 30
2017 30
2018 34
2019 44
2020 38
2021 47
2022 46
2023 34
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

629 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Duodenal Carcinoma"
Page 1
AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States.
Draganov PV, Wang AY, Othman MO, Fukami N. Draganov PV, et al. Clin Gastroenterol Hepatol. 2019 Jan;17(1):16-25.e1. doi: 10.1016/j.cgh.2018.07.041. Epub 2018 Aug 2. Clin Gastroenterol Hepatol. 2019. PMID: 30077787 Review.
Best Practice Advice 4: Endoscopic submucosal dissection may be considered in selected patients with Barrett's esophagus with the following features: large or bulky area of nodularity, lesions with a high likelihood of superficial submucosal invasion, recurrent dysplasia, …
Best Practice Advice 4: Endoscopic submucosal dissection may be considered in selected patients with Barrett's esophagus with the following …
Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Vanbiervliet G, Strijker M, Arvanitakis M, Aelvoet A, Arnelo U, Beyna T, Busch O, Deprez PH, Kunovsky L, Larghi A, Manes G, Moss A, Napoleon B, Nayar M, Pérez-Cuadrado-Robles E, Seewald S, Barthet M, van Hooft JE. Vanbiervliet G, et al. Endoscopy. 2021 Apr;53(4):429-448. doi: 10.1055/a-1397-3198. Epub 2021 Mar 16. Endoscopy. 2021. PMID: 33728632 Free article.
1: ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not proven.Strong recommendation, low quality evidence. 2: ESGE recommends endoscopic ultrasound and abdominal magnetic resonance cholangiopancreatography (MRCP) for staging of ampullary tumors.Strong …
1: ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not proven.Strong recommendation, low quality evidence. 2: ES …
Duodenal leiomyosarcoma.
Petralia GA, Hansen PD, Bowyer RC, Williamson RC. Petralia GA, et al. Dig Surg. 1999;16(1):22-5. doi: 10.1159/000018689. Dig Surg. 1999. PMID: 9949263
Malignant stromal tumours of the duodenum are rare. The efficacy of surgical resection for duodenal leiomyosarcoma was assessed in 5 patients treated over an 11-year period, probably the largest series treated by a single surgeon. ...Two patients developed complications: a …
Malignant stromal tumours of the duodenum are rare. The efficacy of surgical resection for duodenal leiomyosarcoma was assessed in 5 …
Safety and efficacy of surgical and endoscopic resection in the treatment of duodenal subepithelial lesions.
Li C, Liang C, Wang X, Le M, Liu D, Tan Y. Li C, et al. Surg Endosc. 2022 Jun;36(6):4145-4153. doi: 10.1007/s00464-021-08740-3. Epub 2021 Sep 22. Surg Endosc. 2022. PMID: 34550437
BACKGROUND: Duodenal subepithelial lesions (D-SELs) are rare and their resection is challenging. ...Major adverse events rate was 20%. Recurrence rate and distant metastases rate were 4 and 8%, respectively. ...
BACKGROUND: Duodenal subepithelial lesions (D-SELs) are rare and their resection is challenging. ...Major adverse events rate was 20% …
Prognostic factors of non-ampullary duodenal adenocarcinoma.
Hirashita T, Ohta M, Tada K, Saga K, Takayama H, Endo Y, Uchida H, Iwashita Y, Inomata M. Hirashita T, et al. Jpn J Clin Oncol. 2018 Aug 1;48(8):743-747. doi: 10.1093/jjco/hyy086. Jpn J Clin Oncol. 2018. PMID: 29931295
BACKGROUND: Non-ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. ...CONCLUSION: Advanced non-ampullary duodenal adenocarcinoma has a poor prognosis, but chemotherapy possibly improves the prognosis in the pati …
BACKGROUND: Non-ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. ...CONCLUSI …
Safety and feasibility of laparoscopic and endoscopic cooperative surgery for duodenal neoplasm: a retrospective multicenter study.
Nunobe S, Ri M, Yamazaki K, Uraoka M, Ohata K, Kitazono I, Terashima M, Yamagata Y, Tanabe S, Abe N, Tsuji T, Niimi K, Kawakubo H, Tsukada T, Kitashiro S, Ishizuka N, Hiki N; Society for the Study of Laparoscopic Endoscopic Cooperative Surgery. Nunobe S, et al. Endoscopy. 2021 Oct;53(10):1065-1068. doi: 10.1055/a-1327-5939. Epub 2021 Feb 4. Endoscopy. 2021. PMID: 33264810
BACKGROUND: A delayed perforation can often occur after endoscopic treatment for duodenal neoplasms and may be fatal due to leakage of pancreatic and bile juices. We aimed to evaluate the feasibility and safety of laparoscopic and endoscopic cooperative surgery for …
BACKGROUND: A delayed perforation can often occur after endoscopic treatment for duodenal neoplasms and may be fatal due to le …
Usefulness and safety of endoscopic treatment for nonampullary duodenal adenoma and adenocarcinoma.
Seo JY, Hong SJ, Han JP, Jang HY, Myung YS, Kim C, Lee YN, Ko BM. Seo JY, et al. J Gastroenterol Hepatol. 2014 Sep;29(9):1692-8. doi: 10.1111/jgh.12601. J Gastroenterol Hepatol. 2014. PMID: 24720570
There were 40 adenomas and five early-stage adenocarcinomas arising from adenomas. Of the 45 duodenal neoplasms, five patients were treated with DPP, 33 with DEMR, and seven patients with a large duodenal lesion underwent DESD. ...It would be helpful for medi …
There were 40 adenomas and five early-stage adenocarcinomas arising from adenomas. Of the 45 duodenal neoplasms, five patients …
Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK, Wright MJ, Ding D, Javed AA, Cameron JL, Lafaro K, Burns WR, He J, Wolfgang CL, Burkhart RA. Schmocker RK, et al. J Surg Oncol. 2021 Feb;123(2):416-424. doi: 10.1002/jso.26285. Epub 2020 Oct 30. J Surg Oncol. 2021. PMID: 33125737
BACKGROUND: Periampullary neuroendocrine tumors (NETs) arise from the duodenum, ampulla, and periampullary pancreas. Duodenal and ampullary NETs are rare and may have distinct biologic behavior from pancreatic NETs (P-NETs). ...Clinicopathologic data and survival outcomes …
BACKGROUND: Periampullary neuroendocrine tumors (NETs) arise from the duodenum, ampulla, and periampullary pancreas. Duodenal and amp …
Assessment of Duodenal Adenomas and Strategies for Curative Therapy.
Pavlovic-Markovic A, Dragasevic S, Krstic M, Stojkovic Lalosevic M, Milosavljevic T. Pavlovic-Markovic A, et al. Dig Dis. 2019;37(5):374-380. doi: 10.1159/000496697. Epub 2019 Mar 28. Dig Dis. 2019. PMID: 30921797 Free article.
BACKGROUND: The increasing incidence of duodenal neoplasm has underlined different methods of resection depending on the clinical presentation, endoscopic features and histopathology. ...SUMMARY: Among a variety of duodenal lesions, including neuroendocrine tumors a …
BACKGROUND: The increasing incidence of duodenal neoplasm has underlined different methods of resection depending on the clinical pre …
Endoscopic papillectomy: indications, techniques, and results.
De Palma GD. De Palma GD. World J Gastroenterol. 2014 Feb 14;20(6):1537-43. doi: 10.3748/wjg.v20.i6.1537. World J Gastroenterol. 2014. PMID: 24587629 Free PMC article. Review.
Endoscopic papillectomy (EP) is currently accepted as a viable alternative therapy to surgery in sporadic ampullary adenoma and has been reported to have high success and low recurrence rates. At present, the indications for EP are not yet fully established. ...Recurren
Endoscopic papillectomy (EP) is currently accepted as a viable alternative therapy to surgery in sporadic ampullary adenoma and has been rep …
629 results